{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:40:52Z","timestamp":1753890052738,"version":"3.41.2"},"reference-count":25,"publisher":"Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,28]]},"DOI":"10.31744\/einstein_journal\/2025ao1343","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T14:08:14Z","timestamp":1745935694000},"source":"Crossref","is-referenced-by-count":0,"title":["Quality assessment of clinical practice in neuro-oncology"],"prefix":"10.31744","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5326-9092","authenticated-orcid":false,"given":"Renata Carolina Acri Nunes","family":"Miranda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3433-6867","authenticated-orcid":false,"given":"Suzana Maria Fleury","family":"Malheiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5228-2033","authenticated-orcid":false,"given":"Andr\u00e9 Felix","family":"Gentil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3247-3123","authenticated-orcid":false,"given":"Gisele Sampaio","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3941-2574","authenticated-orcid":false,"given":"Fabiana de Campos Cordeiro","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2361-254X","authenticated-orcid":false,"given":"S\u00e9rgio Eduardo Alonso","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4956-5542","authenticated-orcid":false,"given":"Lu\u00eds Ot\u00e1vio Sales","family":"Caboclo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16942","reference":[{"journal-title":"Brain and Other Nervous System C\u00e2ncer- patient version","author":"National Cancer Institute (NCI)","key":"key20250429140805_B1","unstructured":"1. National Cancer Institute (NCI). Brain and Other Nervous System C\u00e2ncer- patient version. Bethesda: NCI; [cited 2023 Apr 27]. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/brain.html"},{"author":"International Agency for Research on Cancer (IARC)","key":"key20250429140805_B2","unstructured":"2. International Agency for Research on Cancer (IARC). France: IARC; [cited 2023 Aug 1]. Available from: https:\/\/gco.iarc.fr\/today\/home"},{"issue":"12","key":"key20250429140805_B3","first-page":"iv1","volume":"22","author":"Ostrom","year":"2020","unstructured":"3. Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017. Neuro Oncol. 2020;22(12 Suppl 2):iv1-iv96. Erratum in: Neuro Oncol. 2022;24(7):1214.","journal-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017"},{"key":"key20250429140805_B4","author":"Instituto Nacional de C\u00e2ncer (INCA)","year":"2023","unstructured":"4. Instituto Nacional de C\u00e2ncer (INCA). Estimativa. Rio de Janeiro: INCA; 2023 [citado 2023 Dez 2023]. Dispon\u00edvel em: https:\/\/www.gov.br\/inca\/pt-br\/assuntos\/cancer\/numeros\/estimativa","journal-title":"Estimativa"},{"year":"2023","author":"Brasil","key":"key20250429140805_B5","unstructured":"5. Brasil. Minist\u00e9rio da Sa\u00fade. Win T. Bras\u00edlia (DF): Minist\u00e9rio da Sa\u00fade; 2023 [citado 2023 Abr 27]. Dispon\u00edvel em: https:\/\/datasus.saude.gov.br\/"},{"issue":"1","key":"key20250429140805_B6","article-title":"An Evaluation of the Use of Performance Measures in Health Care","volume":"4","author":"Damberg","year":"2012","unstructured":"6. Damberg CL, Sorbero ME, Lovejoy SL, Lauderdale K, Wertheimer S, Smith A, et al. An Evaluation of the Use of Performance Measures in Health Care. Rand Health Q. 2012;1(4):3.","journal-title":"Rand Health Q"},{"key":"key20250429140805_B7","doi-asserted-by":"crossref","first-page":"i13","DOI":"10.1093\/intqhc\/mzg080","article-title":"Indicators to improve clinical quality across an integrated health care system","volume":"15","author":"Ballard","year":"2003","unstructured":"7. Ballard DJ. Indicators to improve clinical quality across an integrated health care system. Int J Qual Health Care. 2003;15 Suppl 1:i13-23.","journal-title":"Int J Qual Health Care"},{"issue":"21","key":"key20250429140805_B8","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1212\/WNL.0000000000001965","article-title":"Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary","volume":"85","author":"Rae-Grant","year":"2015","unstructured":"8. Rae-Grant A, Bennett A, Sanders AE, Phipps M, Cheng E, Bever C. Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary. Neurology. 2015;85(21):1904-8. Erratum in: Neurology. 2016; 86(15):1465. Review.","journal-title":"Neurology"},{"issue":"12","key":"key20250429140805_B9","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1080\/03007995.2018.1502165","article-title":"Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson's disease: a multi-country Delphi-panel approach","volume":"34","author":"Antonini","year":"2018","unstructured":"9. Antonini A, Stoessl AJ, Kleinman LS, Skalicky AM, Marshall TS, Sail KR, et al. Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson's disease: a multi-country Delphi-panel approach. Curr Med Res Opin. 2018; 34(12):2063-73.","journal-title":"Curr Med Res Opin"},{"key":"key20250429140805_B10","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1002\/ana.21556","article-title":"Outcomes research in amyotrophic lateral sclerosis: lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education database","volume":"65","author":"Miller","year":"2009","unstructured":"10. Miller RG, Anderson F, Brooks BR, Mitsumoto H, Bradley WG, Ringel SP; ALS CARE Study Group. Outcomes research in amyotrophic lateral sclerosis: lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education database. Ann Neurol. 2009;65 Suppl 1:S24-8.","journal-title":"Ann Neurol"},{"key":"key20250429140805_B11","author":"International Consortium for Health Outcomes Measurement (ICHOM)","year":"2023","unstructured":"11. International Consortium for Health Outcomes Measurement (ICHOM). Connect SI. United States of America: ICHOM; 2023 [cited 2023 Mar 2]. Available from: https:\/\/connect.ichom.org\/patient-centered-outcome-measures\/stroke\/","journal-title":"Connect SI"},{"key":"key20250429140805_B12","author":"American Heart Association (AHA)","year":"2023","unstructured":"12. American Heart Association (AHA). get with the Guidelines\u00ae - Stroke. Dallas, TX: AHA; 2023 [cited 2023 Mar 2]. Available from: https:\/\/www.heart.org\/en\/professional\/quality-improvement\/get-with-the-guidelines\/get-with-the-guidelines-stroke","journal-title":"get with the Guidelines\u00ae - Stroke"},{"year":"2023","author":"American Society of Clinical Oncology (ASCO)","key":"key20250429140805_B13","unstructured":"13. American Society of Clinical Oncology (ASCO). Alexandria, VA: ASCO; 2023 [cited 2023 Mar 2]. Available from: https:\/\/asco.org\/"},{"issue":"6","key":"key20250429140805_B14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1200\/JOP.2014.001206","article-title":"Welcoming the era of quality improvement in neuro-oncology","volume":"10","author":"Norden","year":"2014","unstructured":"14. Norden AD. Welcoming the era of quality improvement in neuro-oncology. J Oncol Pract. 2014;10(6):371-2.","journal-title":"J Oncol Pract"},{"issue":"6","key":"key20250429140805_B15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1200\/JOP.2014.001556","article-title":"Improving the quality of care for patients diagnosed with glioma during the perioperative period","volume":"10","author":"Riblet","year":"2014","unstructured":"15. Riblet NB, Schlosser EM, Homa K, Snide JA, Jarvis LA, Simmons NE, et al. Improving the quality of care for patients diagnosed with glioma during the perioperative period. J Oncol Pract. 2014;10(6):365-70.","journal-title":"J Oncol Pract"},{"key":"key20250429140805_B16","author":"American Academy of Neurology Institute (AANI)","year":"2023","unstructured":"16. American Academy of Neurology Institute (AANI). Society for Neuro-Oncology (SNO). Neuro-Oncology Quality Measurement Set. U.S.: AANI; SNO; 2023 [cited 2023 Apr 27]. Available from: https:\/\/www.aan.com\/siteassets\/home-page\/policy-and-guidelines\/quality\/quality-measures\/18neurooncmeasurementset_pg.pdf","journal-title":"Neuro-Oncology Quality Measurement Set"},{"journal-title":"Brain tumours (primary) and brain metastases in adults","year":"2021","key":"key20250429140805_B17","unstructured":"17. Brain tumours (primary) and brain metastases in adults. London: National Institute for Health and Care Excellence (NICE); 2021 Jan 29. (NICE Guideline, No. 99.). [cited 2023 Aug 27]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK544711\/"},{"issue":"3","key":"key20250429140805_B18","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1200\/OP.20.00233","article-title":"Genesis of Quality Measurements to Improve the Care Delivered to Patients With Brain Metastases","volume":"17","author":"Silvestre","year":"2021","unstructured":"18. Silvestre J, Gosse T, Read P, Gentzler R, Purow B, Asthagiri A, et al. Genesis of Quality Measurements to Improve the Care Delivered to Patients With Brain Metastases. JCO Oncol Pract. 2021;17(3):e397-e405.","journal-title":"JCO Oncol Pract"},{"issue":"6","key":"key20250429140805_B19","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"Louis","year":"2016","unstructured":"19. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016;131(6):803-20. Review.","journal-title":"Acta Neuropathol"},{"issue":"8","key":"key20250429140805_B20","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis","year":"2021","unstructured":"20. Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231-51. Review.","journal-title":"Neuro Oncol"},{"key":"key20250429140805_B21","author":"American Society of Anesthesiologists (ASA)","year":"2023","unstructured":"21. American Society of Anesthesiologists (ASA). ASA physical status classification system. EUA: ASA; 2023 [cited 2023 Mar 2]. Available from: https:\/\/www.asahq.org\/standards-and-practice-parameters\/statement-on-asa-physical-status-classification-system.","journal-title":"ASA physical status classification system"},{"issue":"33","key":"key20250429140805_B22","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1200\/JCO.23.01059","article-title":"RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults","volume":"41","author":"Wen","year":"2023","unstructured":"22. Wen PY, van den Bent M, Youssef G, Cloughesy TF, Ellingson BM, Weller M, et al. RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults. J Clin Oncol. 2023; 41(33):5187-99.","journal-title":"J Clin Oncol"},{"issue":"3","key":"key20250429140805_B23","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/neuonc\/noad234","article-title":"The impact of the COVID-19 pandemic on treatment patterns in glioblastoma","volume":"26","author":"Neff","year":"2024","unstructured":"23. Neff C, Price M, Cioffi G, Waite KA, Kruchko C, Iorgulescu JB, et al. The impact of the COVID-19 pandemic on treatment patterns in glioblastoma. Neuro Oncol. 2024;26(3):581-3.","journal-title":"Neuro Oncol"},{"key":"key20250429140805_B24","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noab180.144","article-title":"P14.22 Quality indicators in neuro-oncology: modified Delphi process for the development of a quality indicator set for assessment of glioma care","volume":"23","author":"Vanhauwaert","year":"2021","unstructured":"24. Vanhauwaert DJ, Pinson H, De Schutter H, Van Eycken E, De Vleeschouwer S, Boterberg T. P14.22 Quality indicators in neuro-oncology: modified Delphi process for the development of a quality indicator set for assessment of glioma care. Neuro Oncol. 2021;23(Suppl 2):ii42.","journal-title":"Neuro Oncol"},{"issue":"2","key":"key20250429140805_B25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11060-022-03971-3","article-title":"Quality indicators in neuro-oncology: Review of the literature and development of a new quality indicator set for glioma care through a two-round Delphi survey","volume":"157","author":"Vanhauwaert","year":"2022","unstructured":"25. Vanhauwaert D, Pinson H, Sweldens C, Du Four S, Van Eycken L; QINO consortium; De Schutter H, De Vleeschouwer S, Boterberg T. Quality indicators in neuro-oncology: Review of the literature and development of a new quality indicator set for glioma care through a two-round Delphi survey. J Neurooncol. 2022;157(2):365-76.","journal-title":"J Neurooncol"}],"container-title":["einstein (S\u00e3o Paulo)"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T14:08:17Z","timestamp":1745935697000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.einstein.br\/article\/quality-assessment-of-clinical-practice-in-neuro-oncology\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":25,"alternative-id":["10.31744\/einstein_journal\/2025AO1343"],"URL":"https:\/\/doi.org\/10.31744\/einstein_journal\/2025ao1343","relation":{},"ISSN":["1679-4508","2317-6385"],"issn-type":[{"type":"print","value":"1679-4508"},{"type":"electronic","value":"2317-6385"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"eAO1343"}}